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Abstract
The study aimed to gain consensus on key priorities for developing breathlessness rehabilitation services for
patients with chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF). Seventy-four
invited stakeholders attended a 1-day conference to review the evidence base for exercise-based rehabilitation
in COPD and CHF. In addition, 47 recorded their views on a series of statements regarding breathlessness
rehabilitation tailored to the needs of both patient groups. A total of 75% of stakeholders supported symptom-
based rather than disease-based rehabilitation for breathlessness with 89% believing that such services would
be attractive for healthcare commissioners. A total of 87% thought patients with CHF could be exercised using
COPD training principles and vice versa. A total of 81% felt community-based exercise training was safe for
patients with severe CHF or COPD, but only 23% viewed manual-delivered rehabilitation an effective
alternative to supervised exercise training. Although there was strong consensus that exercise training was
a core component of rehabilitation in CHF and COPD populations, only 36% thought that this was the ‘most
important’ component, highlighting the need for psychological and other non-exercise interventions for
breathlessness. Patients with COPD and CHF face similar problems of breathlessness and disability on a
background of multi-morbidity. Existing pulmonary and cardiac rehabilitation services should seek synergies
to provide sufficient flexibility to accommodate all patients with COPD and CHF. Development of new
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services could consider adopting a patient-focused rather than disease-based approach. Exercise training is a
core component, but rehabilitation should include other interventions to address dyspnoea, psychological and
education needs of patients and needs of carers.
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Introduction
Breathlessness is one of the commonest reasons for
people seeking emergency department care. In older
adults, common underlying medical conditions include
chronic obstructive pulmonary disease (COPD) or
chronic heart failure (CHF) and often both.1–3 Together,
COPD and CHF account for some twomillion inpatient
bed days per year in the United Kingdom, with COPD
responsible for 1 in 8 and CHF for 1 in 20 of all emer-
gency hospital admissions.4,5 Annual direct healthcare
costs to the National Health Service (NHS) attributed to
COPD and CHF are estimated to be 800 million GBP
and 1.8 billion GBP, respectively.4,5
International guidelines, such as the National Insti-
tute for Health and Care Excellence (NICE), recom-
mend CHF patients should be offered supervised,
exercise-based rehabilitation6 and that exercise-
based pulmonary rehabilitation (PR) should be
offered to COPD patients who consider themselves
functionally disabled, including those who have had
a recent hospitalization for an exacerbation.6 Whereas
PR is designed to cater primarily for older chronic
respiratory disease patients (such as COPD), the
cardiac rehabilitation (CR) population is more hetero-
geneous, ranging from secondary prevention in
post-myocardial infarction (MI) and cardiothoracic
surgery patients3 to older patients with severe CHF
and multi-morbidity. Currently, only 4.4% of the
82,127 patients undergoing CR in England, Wales
and Northern Ireland each year have a primary diag-
nosis of CHF.3 There are multiple reasons for this but
existing CR services place an emphasis upon post-MI,
percutaneous coronary intervention and coronary
artery bypass surgery patients (77% of CR patients)3
and there may be capacity and funding issues.7 The
Cardiovascular Disease Outcomes Strategy (2013)
has set an ambition for CHF services to increase
uptake to exercise-based CR to 33% over the next 5
years.8 Although CR for CHF patients is slowly
increasing, there is limited likelihood of meeting the
stated ambition of the NHS without a significant
rethink of how such services are delivered.
Historically, there has been little or no collabora-
tion between respiratory and cardiac practitioners in
provision of rehabilitation services. However, there is
considerable overlap between the symptom-based
needs for rehabilitation of CHF and COPD patients.
Both groups of patients are generally older, chroni-
cally breathless with multi-morbidity and frailty and
are limited by common manifestations outside the
primary site of disease such as skeletal muscle
dysfunction.9
Breathlessness and frailty, common to both
COPD and CHF, are two of the three research
themes prioritized by the Collaboration for Leader-
ship and Applied Health Research and Care
(CLAHRC) Northwest London (http://clahrc-north-
westlondon.nihr.ac.uk) with the goal of improving
patient symptoms, experiences and outcomes. With
these themes in mind, CLAHRC Northwest London
brought together multidisciplinary stakeholders with
expertise in COPD, CHF and cardiopulmonary reha-
bilitation to generate consensus on key elements of
rehabilitation services that could accommodate the
needs of chronically breathless patients.
This article reviews the evidence base for exercise-
based rehabilitation in COPD and CHF. Furthermore,
the article provides input from the invited stake-
holders on practical considerations, including key
components of a rehabilitation programme, patient
uptake and adherence, and how and where rehabilita-
tion is delivered. This should inform future consensus
for wider availability of PR, CR and generic breath-
lessness rehabilitation services.
Methods
Seventy four invited stakeholders attended a 1-day
conference, entitled ‘Common rehabilitation for
breathlessness: building consensus’. In a series of pre-
sentations, speakers presented the evidence base for
exercise training in CHF and COPD, described the
challenges of assuring quality exercise-based rehabi-
litation in routine practice and reviewed ongoing
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hospital and community-based rehabilitation initia-
tives for older patients with breathlessness.
A discussion was conducted about the similarities
and differences between CR and PR, the reasons why
low patient uptake and adherence to rehabilitation
exist and likely barriers to joint service provision.
At the end of the conference, invited delegates were
asked to record their views on a series of statements in
relation to the development of breathlessness rehabi-
litation services. To maintain impartiality, the votes of
invited speakers and core CLAHRC for NW London
staff were excluded, leaving the views of 47 delegates
to be recorded. The healthcare disciplines of respon-
dents are summarized in Figure 1.
Results
Evidence base for exercise training in heart failure
The Cochrane systematic review and meta-analysis
by Sagar and colleagues identified 33 randomized
controlled trials (RCTs) comparing exercise training
versus no exercise/usual care in a total of 4740
patients with CHF with reduced ejection fraction
(HFrEF) or preserved ejection fraction (HFpEF).
However, the majority had HFrEF (< 40%) and New
York Heart Association (NYHA) class II and III.10
The interventions in some trials included an education
component. The review only included studies with
one or more of the following outcomes reported: (1)
mortality, (2) hospital admission, (3) health-related
quality of life (HRQoL) and (4) costs and cost-
effectiveness.
This meta-analysis reported that exercise-based
rehabilitation is associated with reduced risk of over-
all and CHF-related hospitalization at 12 months,
compared with usual care (relative risk (RR): 0.75,
95% CI [0.62–0.92]; 0.61, 95% CI [0.46–0.80],
respectively) and clinically important improvements
in HRQoL as assessed by the Minnesota Living with
Heart Failure (HF) scale.10 There was no significant
impact on all-cause mortality with exercise-based
rehabilitation at 12 months (RR: 0.92, 95% CI
[0.67–1.26]), though there was a trend towards
reduced mortality at follow-up beyond 1 year (RR:
0.80, 95% CI [0.75–1.02]).
The trial interventions were highly heteroge-
neous, that is, overall exercise duration from 15 min-
utes to 120 minutes, two to seven sessions per week,
at an intensity of 40% of maximal heart rate to 85%
of maximal oxygen uptake. In most trials, the need
for continuous electrocardiogram (ECG) monitoring
during exercise training was not specified. Meta-
regression analyses showed no impact of type of
rehabilitation (exercise-only interventions vs. exer-
cise plus other interventions), type of exercise (aero-
bic alone vs. aerobic and strength), dose or setting
(centre/hospital vs. home) on the specified
outcomes.
A recent meta-analysis including six RCTs across
276 patients with HFpEF has shown similar benefits
to those for patients with HFrEF, in terms of improve-
ment in exercise capacity and HRQoL.11 However,
data on the impact of exercise-based rehabilitation
on mortality in HPpEF are currently lacking.
Figure 1. Disciplines of those providing feedback on breathlessness services. AHP: Allied Health Professional; CLAHRC:
Collaboration for Leadership and Applied Health Research and Care.
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Evidence base for pulmonary rehabilitation
in COPD
In stable COPD, a Cochrane review (65 RCTs,
3822 patients) compared the effects of PR versus
usual care on HRQoL and functional and maximal
exercise capacity.12 Meta-analysis showed statisti-
cally significant and clinically important improve-
ments in HRQoL (four domains of the Chronic
Respiratory Questionnaire (CRQ) and St. George’s
Respiratory Questionnaire (SGRQ)), maximal exer-
cise capacity (incremental shuttle walk, incremen-
tal cycle ergometry) and functional exercise
capacity (6-minute walk test).12 This systematic
review did not include outcomes of hospital admis-
sions or mortality.
The role of PR for medically unstable patients has
also been studied in COPD. A Cochrane review and
meta-analysis (9 RCTs, 432 patients) showed that PR
following a COPD exacerbation (typically severe
requiring hospitalization) reduced hospital admis-
sions (pooled odds ratio (OR) 0.22, 95% CI [0.08–
0.58]), over an average of 25 weeks follow-up.13 PR
also led to improvements in secondary outcomes
including exercise capacity and HRQoL (CRQ and
SGRQ). No adverse events in terms of increased mor-
tality were seen with PR in this population. Indeed,
PR significantly reduced mortality (OR 0.28, 95% CI
[0.10–0.84]) over an average of 107 weeks follow-up,
although mortality data were only recorded in a small
number of patients.13
There is little RCT data examining the effects of
exercise-based rehabilitation on patients with both
CHF and COPD, although it is likely that previous
rehabilitation trials in patients with COPD included
those with undiagnosed CHF and vice versa in reha-
bilitation trials of patients with CHF. A recent
subgroup analysis of a large multicentre RCT of
exercise-based CR, HF-ACTION demonstrated that
CHF patients with coexistent COPD responded as
well to exercise training as those with CHF and no
evidence of COPD.1
Optimal setting for rehabilitation
In COPD, there is no clear evidence showing advan-
tages of hospital-based rehabilitation compared to
community- or home-based rehabilitation.14,15 A sub-
group analysis of patients in the Cochrane review of
stable COPD indicated a significant difference in
treatment effect for all domains of the CRQ, with
higher mean changes following hospital-based PR
than community-based PR, but there was no differ-
ence in SGRQ scores.12
The Self-Management Programme of Activity,
Coping and Education (SPACE) for COPD is a
6-week home-based self-management intervention
for COPD that has been shown to improve CRQ
dyspnoea, fatigue and emotion scores, exercise per-
formance, anxiety and disease knowledge at 6 weeks
compared with usual care (excluding PR).16 At
6 months, the superiority of SPACE was sustained for
measures of anxiety, exercise performance and
smoking status but not for dyspnoea. An ongoing
NIHR-funded trial (ISRCTN03142263) is examining
the feasibility of delivering web-based rehabilitation,
based on the SPACE for COPD manual, compared to
conventional centre-based rehabilitation.
A recent systematic review and meta-analysis of 17
RCTs in 2172 participants undergoing CR directly
compared delivery in a centre-based versus home-
based setting.17 This systematic review included five
studies of 345 patients with CHF with NYHA class II
and III. The overall results found no significant dif-
ference in mortality, cardiac events, exercise capacity
or HRQoL outcomes between the two settings.17
However the majority of studies recruited a lower risk
patient and excluded those with significant arrhyth-
mia or ischaemia.17
Rehabilitation Enablement in Heart Failure
(REACH-HF) is an ongoing NIHR Programme Grant
(ISRCTN25032672) investigating the effectiveness
and cost-effectiveness of a self-help rehabilitation
manual (with support from specially trained cardiac
nurses) for HFrEF and HFpEF patients and their
carers compared to a no-CR control. Outcomes of this
intervention will be forthcoming.
Other rehabilitation interventions, including
home-based telemonitored Nordic walking training,
have proved well accepted, safe and effective, with
good adherence among patients with CHF.18 There is
growing evidence for the potential of web-based and
other technological interventions for rehabilitation,
with beneficial effects reported on HRQoL. An
example includes encouraging patients with COPD
to perform daily endurance walking according to the
tempo of music from a programme installed on their
mobile phone.19
Non-exercise interventions
The experience of breathlessness comprises both
the sensation itself and the patient’s reaction to
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that sensation. Both can be changed by modifying
central perception. Most CR and PR programmes
include an educational component as well as
exercise and some also include management of
anxiety and depression, support for carers and
other aids to reduce disability and support reha-
bilitation. Patients undergoing PR have rated
DVD-based educational sessions, alongside a
supervised exercise programme, equivalent to
spoken sessions.20
Breathlessness services have also been reported in
the palliative care literature. One example is the Cam-
bridge Breathlessness Intervention Service (CBIS)
that comprises a multidisciplinary team offering
patients and carers a broad range of support in addi-
tion to exercise training (Table 1). This includes use
of a handheld fan blowing air across the nose and
mouth, which has been shown to reduce the sensation
of breathlessness21 and training in recovery and
pursed lip breathing.
CBIS was recently evaluated in a mixed methods
RCT of patients with advanced cancer (45% lung
cancer).22 In the study, the intervention comprised
one to four face-to-face visits and four to six tele-
phone contacts with the service over a period of
weeks. Interventions were offered on the basis of
an initial assessment and delivered mainly in
patients’ homes during visits lasting 1–1.5 hours and
accompanied by a medicines review. The co-
morbidity burden (as measured by the Charlson
index) and degree of breathlessness were high in
both arms, and it is likely that the trial population
included patients with coexistent COPD, CHF or
both.
CBIS reduced patient distress due to breathless-
ness (primary outcome: 1.29; 95% CI [2.57 to
0.005]; p ¼ 0.049) significantly more than stan-
dard care, with 94% of respondents reporting a pos-
itive impact.22 The complex intervention reduced
fear and worry, increased confidence in managing
breathlessness and proved to be more cost effective
than standard care, with reduced healthcare contacts
and need for informal care. Patients and carers con-
sistently identified specific and repeatable aspects of
the CBIS model and interventions that were helpful.
The findings have been replicated in another similar
RCT of patients with advanced disease and refrac-
tory breathlessness (the majority with COPD),23
suggesting that helping patients (regardless of
underlying disease) to modify the central perception
of breathlessness is an important part of
rehabilitation.
Joint COPD/HF rehabilitation initiatives
An outpatient PR programme designed for patients
with COPD has proved equally effective for a CHF
population treated in the same location by the same
therapists.24
In a randomized trial of the joint intervention, 57
patients with CHF (mean left ventricular ejection
fraction 30%) were assigned to 7 weeks of PR or usual
care, whilst 55 patients with COPD carried out the
same PR programme.24 Of these, 27 CHF and 44
COPD patients completed PR and 17 patients with
CHF completed usual care.24
During a 7-week programme, patients underwent
supervised physical training (endurance training and
education) twice weekly for 2 hours, together with
daily unsupervised home training (walking at an indi-
vidually tailored speed equivalent to 85% peak oxy-
gen consumption derived from each patient’s
incremental shuttle walk test (ISWT)). Patients also
performed peripheral muscle exercises three times a
week (once a week supervised in hospital; twice a
week at home) using free weights for the upper limbs
Table 1. Non-exercise and self-management components
of a potential rehabilitation programme for breathlessness.
Developed from the study by Higginson IJ et al. and Evans
RA.23,24
Explanation and reassurance
Handheld fan
Breathing control
Activity pacing and exercise
Anxiety management
Psychological support
Information fact sheets
Emergency plan for exacerbations or
breathing crises
Advice about positioning to reduce
work of breathing (rest, recovery
and activity)
Education (patient and carer)
Lifestyle adjustment
Individualized
exercise plan
Relaxation and
visualization
Airway clearance
techniques
Nutrition and
hydration advice
Sleep hygiene
Brief cognitive
therapy
Pharmacological
review
Well-being
intervention
Formal relaxation
therapy
Mindfulness CD
Referral to
specialist services
Sex and relations
Support for carers
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and conditioning exercises for the lower limbs.
Patients from both groups trained together and were
supervised by the same therapists. No ECG monitor-
ing was performed during exercise training, although
all patients underwent a full cardiopulmonary exer-
cise test to exclude unstable arrhythmias prior to PR.
Significant improvements in ISWT distance and
endurance shuttle walk time were seen in the CHF
patients undergoing PR compared to those rando-
mized to usual care (both p < 0.001; effect sizes
0.57 and 0.95, respectively). Improvements in exer-
cise performance and HRQoL were similar for
patients with CHF and COPD who participated in the
PR programme. No significant adverse events were
noted, and a similar rate of dropouts was observed in
the CHF groups undergoing PR and usual care. Train-
ing as a combined group did not adversely affect out-
comes for patients with COPD, which were similar to
those seen in patients previously treated separately
from CHF patients in the programme. This study
demonstrates that combined exercise rehabilitation
for COPD and CHF is feasible and effective.
Quality assuring exercise-based rehabilitation
Ensuring high-quality services as part of routine prac-
tice requires continued collection and monitoring of
data, and useful lessons can be learned from the
National Audit of Cardiac Rehabilitation.3 Although
there has been continued gradual improvement over
time, the NACR 2015 audit still showed that few
regions were able to meet the NICE/DH recommen-
dation of assessing patients for CR within 10 days of
their initiating event or starting rehabilitation within
25 days from referral. Whilst improvements in the
proportion of patients achieving 150 minutes of exer-
cise per week were seen across all regions and pro-
grammes, there was considerable variation both in
pre- and post-CR levels across the United Kingdom.
Variations also occurred in patients achieving
improvements in anxiety and depression, underlining
the importance of pre- and post-CR assessments to
ensure that standards are met.
The NACR 2015 report also highlights shortfalls
within the multidisciplinary teams supervising CR
programmes3. Thus, whilst 96% of programmes
include nurses and 65% include physiotherapists, only
18% include a psychologist.
The NACR and the British Association for Cardiac
Prevention and Rehabilitation have embarked on an
ambitious project to use data on minimum standards,
collected as part of routine practice, to implement a
certification process to ensure that all CR pro-
grammes achieve a basic minimum standard and
achieve high-quality delivery and outcomes.
In contrast to CR, there is little national audit data
for PR. The British Thoracic Society has recently
developed guidelines for PR25 and quality standards
for PR. The forthcoming first national audit of PR
services in the United Kingdom will provide a basis
for future accreditation and certification of PR ser-
vices for quality assurance.
The development of such quality standards and
regular audit can help to inform joint CHF/COPD
services, but it is clear from the evidence presented
that questions remain about where, when and how
rehabilitation should be provided.
Conference stakeholder discussion
There was a high level of agreement on a number of
areas (Table 2). Rehabilitation for COPD and CHF
should be symptom rather than disease based and the
same principles of exercise training can be used for
both CHF and COPD. Whilst exercise was seen as a
core component of breathlessness rehabilitation, it
was not considered the only important aspect. Despite
the relative lack of evidence concerning psychologi-
cal aspects of rehabilitation, the contribution of men-
tal well-being to breathlessness was considered as
important as disease severity, underlining the value
of psychological input for joint CR/PR services.
Small differences in educational requirements for
patients with CHF and COPD were not seen as a
barrier to joint rehabilitation. Whilst some tailoring
would be needed for disease-specific information
such as medications and pathophysiology, it was
agreed that general requirements for health promotion
are broadly similar for CHF and COPD. Advice about
routine healthy exercise, outside any formalized
group training, should be tailored to individual
circumstances.
It was thought that community-based exercise
training was safe for patients with severe CHF or
COPD. In contrast to PR staff, CR practitioners might
expect a recent echocardiogram or ECG for CHF
patients in order to tailor exercise to individual needs
as well as ECG monitoring during exercise testing or
training. Previous data suggest that adverse events
from exercise training in cardiac patients are rare.26
Keteyian and colleagues reported the safety of
symptom-limited cardiopulmonary exercise testing
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in 2037 patients (NYHA class II to IV; left ventricu-
lar ejection fraction less than 35%) participating in
the HF-ACTION trial; 74% of whom had an implan-
table cardioverter–defibrillator, biventricular pace-
maker or pacemaker. In 4411 exercise tests, there
were no deaths, exacerbation of HF, MI, strokes or
sustained ventricular tachycardia.26 Twenty-seven
tests were stopped due to non-sustained supraventri-
cular or ventricular tachycardia. With this in mind,
senior cardiology specialists from our working group
felt that the potential harms of exercise to patients
with CHF are overplayed. There should be focus on
keeping assessment and care pathways as simple as
possible in order to optimize patient uptake.
Although rehabilitation programmes without contin-
uous ECG monitoring are safe, patients are usually
prescreened with symptom-limited cardiopulmonary
exercise testing.
Participants were almost unanimous in agreeing
that the way interventions are delivered by Healthcare
Professionals (HCPs) has an important influence on
their success. The personal impact of the HCP is too
often dismissed as ‘placebo effect’ when it should be
considered a part of the intervention. There was little
support for breathlessness rehabilitation delivered
exclusively in the home or by a manual as an alterna-
tive to supervised exercise training. However, it was
recognized that breathlessness rehabilitation pro-
grammes need to take account of the fact that many
patients with COPD or CHF are elderly with multiple
morbidities and a proportion would be housebound.
Some would never have participated in gym-based
group exercise, so patient preference must be taken
into account and a flexible, menu-based programme
may best accommodate different patient needs and
choices. Ongoing trials of manual-based interventions
such as the REACH-HF research programme or
SPACE may provide an evidence base in the future
to support alternative approaches to centre-based
supervised exercise training.
Table 2. Building consensus on breathlessness rehabilitation for HF/COPD: areas of agreement. Number and percentage
of participants responding to each statement.a
S. No Statements
Yes No Not sure Blank Total
n % n % n % n % n
1 Patient factors, rather than service provision, are the principal
reasons for poor uptake of cardiac and pulmonary
rehabilitation.
9 19.1% 18 38.3% 16 34.0% 4 8.5% 47
2 Mental well-being is as important a contributor to
breathlessness as disease severity.
41 87.2% 3 6.4% 1 2.1% 2 4.3% 47
3 Common rehabilitation for breathlessness is attractive for
healthcare commissioners.
42 89.4% 1 2.1% 2 4.3% 2 4.3% 47
4 To maximize uptake, common rehabilitation for breathlessness
should be delivered in the patient’s home.
15 31.9% 13 27.7% 15 31.9% 4 8.5% 47
5 Rehabilitation delivered by a manual is an effective alternative to
supervised exercise training.
11 23.4% 19 40.4% 14 29.8% 3 6.4% 47
6 Exercise training is a core component of rehabilitation for
breathlessness.
47 100% 0 0.0% 0 0.0% 0 0.0% 47
7 Exercise training is the most important component of
rehabilitation for breathlessness.
17 36.2% 22 46.8% 4 8.5% 4 8.5% 47
8 Can patients with HF be exercised using COPD training
principles and vice versa.
41 87.2% 0 0.0% 3 6.4% 3 6.4% 47
9 Exercise training based in the community is safe for patients with
severe HF or COPD.
38 80.9% 0 0.0% 6 12.8% 3 6.4% 47
10 Education needs of patients with HF and COPD are more
similar than different.
26 55.3% 10 21.3% 8 17.0% 3 6.4% 47
11 Rehabilitation should be symptom based not disease based. 35 74.5% 2 4.3% 7 14.9% 3 6.4% 47
12 The way that interventions are delivered by healthcare
professionals has an important influence on their success.
45 95.7% 0 0.0% 0 0.0% 2 4.3% 47
COPD: chronic obstructive pulmonary disease; HF: heart failure.
aHighlighted areas reflect areas where consensus of >50% was achieved.
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Discussion
Patients with COPD and CHF conditions share a sim-
ilar disablement process9 and show similar clinical
and physiological benefits from exercise training.27,28
Although rehabilitation services for CHF and COPD
are slowly increasing, current services are unlikely to
meet the needs of eligible patients without significant
reconsideration of how such services are delivered.
Given resource limitations7 – financial and skilled
staffing – there is growing interest in exploring syner-
gies across existing rehabilitation services and com-
missioning rehabilitation programmes that are
symptom based rather than disease based.
There is strong evidence from meta-analyses to
support exercise-based rehabilitation for both patients
with COPD and CHF. However, translation of evi-
dence to routine clinical practice remains challenging.
Although NICE recommended that exercise-based
training for CHF can be incorporated into existing
CR programmes, the traditional CR population
(post-MI and cardiothoracic surgery patients) is
generally fitter and younger, and secondary preven-
tion is the overriding concern rather than manage-
ment of breathlessness. Integration of older,
breathless CHF patients into existing CR groups
may face potential staff and patient barriers.
Although access to CR has improved for patients
with CHF, 12% of CR programmes continue not to
accept patients with CHF, and approximately 4% of
the nearly 80,000 patients undergoing CR in Eng-
land, Wales and Northern Ireland each year have a
primary diagnosis of CHF.3
The PR population is more homogeneous as elig-
ibility is dependent on the level of respiratory dis-
ability.25 Arguably the patient with CHF has more in
common with the patient with COPD than one who
is post-MI. However, secondary prevention is not a
strong component of PR. As eligibility for PR is
dependent on the level of symptoms, current PR
programmes cater less well for patients with mild
disease, despite good evidence to suggest that phys-
ical inactivity and skeletal muscle dysfunction are
prevalent in these groups29,30 and amenable to exer-
cise therapy.29 Furthermore, despite a growing evi-
dence base to support PR in the peri-exacerbation
setting, recent data suggest that PR may not be
acceptable to patients in such populations.31
Therefore, current CR and PR programmes have
strengths and weakness, but there are clear synergies
where closer collaboration between CR and PR
practitioners could improve prevention strategies
and lead to more combined strategies in managing
older patients with breathlessness.
Data on the costs and cost-effectiveness of CR in
patients with CHF are limited. The one UK trial that
included economic information reported a cost of
centre-based CR intervention for functionally
impaired, older patients with CHF of £475 per
patient.32 In a broader UK-based analysis of the
cost-effectiveness of secondary prevention interven-
tions in post-MI patients, CR compared favourably
(£1957 per life year gained (LYG)) with angiotensin
converting enzyme inhibitors (£3398/LYG).33 PR is
also associated with health economic benefits.34 The
London Respiratory Team recently described the
COPD Value Pyramid, which estimated the cost of
PR to be between £2000 and £8000 per quality-
adjusted life year (QALY), well below the £20,000
per QALY that NICE considers cost effective.
There are therefore a number of good clinical,
evidence-based and economic reasons to consider
wider development of cardiac, pulmonary and breath-
lessness rehabilitation services for patients with
COPD or CHF. Looking for synergies between exist-
ing PR and CR services, and tailored exercise rehabi-
litation programmes for CHF may generate
economies of scale that might address the current
shortfall in rehabilitation services for breathless older
patients. These initiatives are likely to be considered
favourably by healthcare commissioners.
In areas where PR and CR services are absent, or
there are gaps in service provision for patients with
CHF or COPD, development of joint breathlessness
rehabilitation services could be considered. Exercise
training principles for COPD and CHF appear broadly
comparable (Table 3),35 and there was stakeholder
consensus that patients with CHF could be exercised
using COPD principles and vice versa. Evans and
colleagues were able to demonstrate that combined
exercise rehabilitation for COPD and CHF is feasible
and effective.24 However, further research is needed
to corroborate this data, particularly in patients with
more severe symptoms (NYHA class IV) and patients
with HFpEF (who tend to be older and have more co-
morbidities). Although exercise is the core compo-
nent of rehabilitation programmes for both COPD and
CHF, psychological and educational aspects are
important. A flexible, ‘menu-based’ programme is
most likely to accommodate patients of different ages,
comorbidities, disease and symptom severity and pre-
vious exercise history.
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Conclusions
There is level 1A evidence (i.e.meta-analyses of RCTs)
for the important health benefits of exercise-based reha-
bilitation in both HF with HFrEF and stable and recent
exacerbation COPD populations. These benefits
include important gains in HRQoL and functional
capacity and reductions in hospital admissions. Due to
the similarities in symptoms, needs and exercise train-
ing in COPD and CHF, there are clear advantages for
seeking synergies between CR and PR programmes.
Although the current RCT evidence is limited, joint
exercise rehabilitation programmes for patients with
COPD or CHF, in the same location by the same
therapists, appear effective, feasible and may have the
potential to unblock capacity limitations for services
commissioned separately. Such a service should
embrace a symptom-based approach to care, that is,
the management of breathlessness, rather than the
more traditional disease-centred approach.
Acknowledgement
We are grateful to Jenny Bryan for writing support with the
manuscript.
Declaration of Conflicting Interests
The author(s) declared the following potential conflicts of
interest with respect to the research, authorship, and/or
publication of this article: Rod S Taylor is a co-author on
a number of Cochrane reviews on cardiac rehabilitation and
is the chief investigator on an ongoing National Institute of
Health Research Programme Grants for Applied Research
(RP-PG-1210-12004): Rehabilitation Enablement in
Chronic Heart Failure (REACH-HF).
Funding
The author(s) disclosed receipt of the following financial
support for the research, authorship, and/or publication of
this article: This work was funded by the National Institute
for Health Research (NIHR) Collaboration for Leadership
in Applied Health Research and Care (CLAHRC) for North
West London. WM and MC are supported by the NIHR
Respiratory and Cardiovascular Biomedical Research
Units at the Royal Brompton and Harefield NHS Founda-
tion Trust and Imperial College London and the CLAHRC
for NW London. The views expressed in this publication
are those of the authors and not necessarily those of the
NHS, the NIHR nor the Department of Health. RT is sup-
ported by the NIHR CLAHRC South West Peninsula at the
Royal Devon and Exeter NHS Foundation Trust. SS is
supported by the NIHR CLAHRC South East Midlands.
References
1. Mentz RJ, Schulte PJ, Fleg JL, et al. Clinical character-
istics, response to exercise training, and outcomes in
patients with heart failure and chronic obstructive pul-
monary disease: findings from Heart Failure and a con-
trolled trial investigating outcomes of exercise training
(HF-ACTION). Am Heart J 2013; 165(2): 193–199.
2. Crisafulli E, Costi S, Luppi F, et al. Role of comorbid-
ities in a cohort of patients with COPD undergoing pul-
monary rehabilitation. Thorax 2008; 63(6): 487–492.
3. British Heart Foundation. National audit of cardiac
rehabilitation annual statistical report. London: British
Heart Foundation, 2015.
4. National Institute for Health and Care Excellence.
NICE support for commissioners and others using the
quality standard for Chronic obstructive pulmonary
disease (COPD), July 2011.
5. National Clinical Guideline Centre. Chronic heart fail-
ure: the management of chronic heart failure in adults
in primary and secondary care. London: National Clin-
ical Guideline Centre, http://guidance.nice.org.uk/
CG108/Guidance/pdf/English (2010).
6. National Institute for Health and Care Excellence.
Chronic obstructive pulmonary disease. Management
of chronic obstructive pulmonary disease in adults in
primary and secondary care (partial update) CG 101,
June 2010.
7. Dalal HM, Wingham J, Palmer J, et al. Why do so few
patients with heart failure participate in cardiac reha-
bilitation? A cross-sectional survey from England,
Wales and Northern Ireland. BMJ Open 2012; 2(2):
e000787.
Table 3. Similarities in exercise training for patients with
COPD and HF
COPD HF
Aerobic lower
limb training
High intensity (60–
80% peak VO2)
High intensity (40–
70% peak VO2)
Duration Minimum 6–12
weeks
Minimum 12 weeks
Frequency Minimum 3 times/
week
Minimum 3 times/
week
Interval
p p
Additional
strength
training
p
High resistance
p
Low resistance
Moderate–high may
be safe
Adjuncts Helium/hyperoxia/
one legged/NIV
?
COPD: chronic obstructive pulmonary disease; HF: heart failure.
Adapted from the study by Evans RA; NIV: Non-invasive ventila-
tion.35
Note: Tick refers to Yes; Question mark refers to Unclear.
Man et al. 237
8. Department of Health. Cardiovascular Disease Out-
comes Strategy. Improving outcomes for people with
or at risk of cardiovascular disease, www.dh.gov.uk/
publications (2013).
9. Gosker HR, Wouters EF, van der Vusse GJ, et al.
Skeletal muscle dysfunction in chronic obstructive
pulmonary disease and chronic heart failure: underly-
ing mechanisms and therapy perspectives. Am J Clin
Nutr 2000; 71(5): 1033–1047.
10. Sagar VA, Davies EJ, Briscoe S, et al. Exercise-based
rehabilitation for heart failure: systematic review and
meta-analysis. Open Heart 2015; 2: e000163.
11. Pandey A, Parashar A, Kumbhani DJ, et al. Exercise
training in patients with heart failure and preserved
ejection fraction: meta-analysis of randomized control
trials. Circ Heart Fail 2015; 8(1): 33–40.
12. McCarthy B, Casey D, Devane D, et al. Pulmonary
rehabilitation for chronic obstructive pulmonary dis-
ease.Cochrane Database Syst Rev 2015; 2: CD003793.
13. Puhan MA, Gimeno-Santos E, Scharplatz M, et al.
Pulmonary rehabilitation following exacerbations of
chronic obstructive pulmonary disease. Cochrane
Database Syst Rev 2011; (10): CD005305.
14. Waterhouse JC, Walters SJ, Oluboyede Y, et al. A
randomised 2  2 trial of community versus hospital
pulmonary rehabilitation for chronic obstructive pul-
monary disease followed by telephone or conven-
tional follow-up. Health Technol Assess 2010;
14(6): 1–140.
15. Maltais F, Bourbeau J, Shapiro S, et al. Effects of
home-based pulmonary rehabilitation in patients with
chronic obstructive pulmonary disease: a randomized
trial. Ann Intern Med 2008; 149(12): 869–878.
16. Mitchell KE, Johnson-Warrington V, Apps LD, et al. A
self-management programme for COPD: a randomised
controlled trial. Eur Respir J 2014; 44(6): 1538–1547.
17. Taylor RS, Dalal H, Jolly K, et al. Home-based versus
centre-based cardiac rehabilitation. Cochrane Data-
base Syst Rev 2015; 8: CD007130.
18. Piotrowicz E, Zielin´ski T, Bodalski R, et al.
Home-based telemonitored Nordic walking training
is well accepted, safe, effective and has high adher-
ence among heart failure patients, including those with
cardiovascular implantable electronic devices: a ran-
domised controlled study. Eur J Prev Cardiol 2015;
22(11): 1368–1377.
19. Liu WT, Huang CD, Wang CH, et al. A mobile
telephone-based interactive self-care system improves
asthma control. Eur Respir J 2011; 37(2): 310–317.
20. Ward S, Sewell L and Singh S. P144 Evaluation of
multidisciplinary pulmonary rehabilitation education
delivered by either DVD or spoken talk. Thorax
2011; 66: A125–A126.
21. Galbraith S, Fagan P, Perkins P, et al. Does the use of a
handheld fan improve chronic dyspnea? A rando-
mized, controlled, crossover trial. J Pain Symptom
Manage 2010; 39(5): 831–838.
22. Farquhar MC, Prevost AT, McCrone P, et al. Is a spe-
cialist breathlessness service more effective and
cost-effective for patients with advanced cancer and
their carers than standard care? Findings of a
mixed-method randomised controlled trial. BMC Med
2014; 12: 194.
23. Higginson IJ, Bausewein C, Reilly CC, et al. An inte-
grated palliative and respiratory care service for
patients with advanced disease and refractory breath-
lessness: a randomised controlled trial. Lancet Respir
Med 2014; 2(12): 979–987.
24. Evans RA, Singh SJ, Collier R, et al. Generic, symp-
tom based, exercise rehabilitation; integrating patients
with COPD and heart failure. Respir Med 2010;
104(10): 1473–1481.
25. Bolton CE, Bevan-Smith EF, Blakey JD, et al. British
Thoracic Society Pulmonary Rehabilitation Guideline
Development Group; British Thoracic Society Stan-
dards of Care Committee. British Thoracic Society
guideline on pulmonary rehabilitation in adults.
Thorax 2013; 68(Suppl 2): ii1–ii30.
26. Keteyian SJ, Isaac D, Thadani U, et al. HF-ACTION
Investigators. Safety of symptom-limited cardiopul-
monary exercise testing in patients with chronic heart
failure due to severe left ventricular systolic dysfunc-
tion. Am Heart J 2009; 158(4 Suppl): S72–S77.
27. Whittom F, Jobin J, Simard PM, et al. Histochemical
and morphological characteristics of the Vastus
lateralis muscle in patients with chronic obstructive
pulmonary disease. Med Sci Sports Exerc 1998; 30:
1467–1474.
28. Hambrecht R, Fiehn E, Yu J, et al. Effects of endurance
training on mitochondrial ultrastructure and fiber type
distribution in skeletal muscle of patients with stable
chronic heart failure. J Am Coll Cardiol 1997; 29:
1067–1073.
29. Jones SE, Maddocks M, Kon SS, et al. Sarcopenia in
COPD: prevalence, clinical correlates and response to
pulmonary rehabilitation. Thorax 2015; 70(3):
213–218.
30. Watz H, Waschki B, Meyer T, et al. Physical activity
in patients with COPD. Eur Respir J 2009; 33(2):
262–272. Erratum in: Eur Respir J 2010; 36(2): 462.
31. Jones SE, Green SA, Clark AL, et al. Pulmonary reha-
bilitation following hospitalisation for acute
238 Chronic Respiratory Disease 13(3)
exacerbation of COPD: referrals, uptake and adher-
ence. Thorax 2014; 69(2): 181–231.
32. Witham MD, Fulton RL, Greig CA, et al. Efficacy
and cost of an exercise program for functionally
impaired older patients with heart failure: a rando-
mized controlled trial. Circ Heart Fail 2012; 5(2):
209–216.
33. Fidan D, Unal B, Critchley J, et al. Economic analysis
of treatments reducing coronary heart disease mortality
in England andWales, 2000–2010.Q JMed 2007; 100:
277–289.
34. Griffiths TL, Phillips CJ, Davies S, et al. Cost effec-
tiveness of an outpatient multidisciplinary pulmonary
rehabilitation programme. Thorax 2001; 56(10):
779–784.
35. Evans RA. Developing the model of pulmonary reha-
bilitation for chronic heart failure. Chron Respir Dis
2011; 8(4): 259–269.
Man et al. 239
